O'Neil Global Advisors’s Halozyme HALO Stock Holding History

O'Neil Global Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,750	Closed	-$249K	–	71
2024 Q2	$249K	Buy	+4,750	New	+$208K	0.12%	39

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

O'Neil Global Advisors's HALO Position: Q3 2024 in Review

O'Neil Global Advisors sold out of Halozyme (HALO) in Q3 2024, closing a stake of 4,750 shares — an estimated $249K sold.

O'Neil Global Advisors first reported a position in HALO in Q2 2024 and held it in 1 quarter. The position peaked at $249K in Q2 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q3 2024.

O'Neil Global Advisors reported no remaining Halozyme position as of Q3 2024 after selling out during the quarter.
O'Neil Global Advisors sold 4,750 Halozyme shares in Q3 2024, an estimated $249K.
O'Neil Global Advisors first reported a position in Halozyme in Q2 2024 and held it in 1 quarter.
O'Neil Global Advisors's Halozyme position peaked at $249K in Q2 2024.
508 funds tracked by Wall St. Rank held Halozyme as of Q3 2024.

Based on O'Neil Global Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.